A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems. (Q43963775)

From Wikidata
Jump to navigation Jump to search
scientific article published on 23 June 2011
edit
Language Label Description Also known as
English
A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems.
scientific article published on 23 June 2011

    Statements

    title
    A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    21704192
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21704192%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    5 February 2020

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q43963775&oldid=2105074302"